Meeting
2023 ASCO Annual Meeting
Polygenic risk scores in assessing lung cancer susceptibility in non-Hispanic White and Black populations.
Authors
Matthew R Trendowski
Wayne State University School of Medicine, Detroit, MI
Matthew R Trendowski , Chrissy Lusk , Angie Wenzlaff , Christine Neslund-Dudas , Shirish M. Gadgeel , Ayman Soubani , Ann G. Schwartz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 10548)
DOI
10.1200/JCO.2023.41.16_suppl.10548
Abstract #
10548
Poster Bd #
181
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
The BARCODE1 pilot study targeting men with increased genetic risk of developing prostate cancer: Examining the feasibility of a community-based screening program using polygenic risk score to target screening.
First Author: Jana Kathlyn McHugh
Poster
2024 ASCO Annual Meeting
Association of a polygenic risk score with risk of abnormal ultrasound findings and ovarian cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
First Author: Sarah Phillips
Poster
2022 ASCO Genitourinary Cancers Symposium
The BARCODE1 study in primary care: Early results targeting men with increased genetic risk of developing prostate cancer—Examining the interim data from a community-based screening program using polygenic risk score to target screening.
First Author: Jana Kathlyn McHugh
Poster
2014 ASCO Annual Meeting
Use of a SNP panel to refine risk estimates in women at high risk of breast cancer: Results from two randomized tamoxifen prevention trials.
First Author: Jack M. Cuzick